Marrone Bio Innovations to Report Third Quarter 2019 Results on Tuesday, November 12th at 4:30 p.m. Eastern Time
November 04 2019 - 8:31AM
Marrone Bio Innovations Inc. (NASDAQ: MBII), an international
leader in sustainable bioprotection and plant health solutions,
will release financial results for the third quarter ended
September 30, 2019, after market close on Tuesday, November 12,
2019.
Management will host an investor conference call
at 1:30 p.m. PST (4:30 p.m. EST) on November 12, 2019, to discuss
Marrone Bio Innovations’ third quarter 2019 financial results,
provide a corporate update, and conclude with a Q&A from
participants. To participate, please use the following
information:
Q3 2019 Conference Call and
Webcast Date: Tuesday, November 12, 2019 Time: 1:30 p.m.
Pacific time (4:30 p.m. Eastern time) U.S. Dial-in: 1-866-575-6539
International Dial-in: 1-323-794-2551 Conference ID: 8693394
Webcast:
http://public.viavid.com/index.php?id=136977
Please dial in at least 10 minutes before the
start of the call to ensure timely participation.
A playback of the call will be available through
December 12, 2019. To listen, call 1-844-512-2921 within the United
States or 1-412-317-6671 when calling internationally. Please use
the replay pin number 8693394. A webcast will also be available for
30 days on the IR section of the Marrone Bio Innovations website or
by clicking here: MBII Q3 2019 Webcast.
About Marrone Bio Innovations
Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented
company leading the movement to more a sustainable world through
the discovery, development and sale of innovative biological
products for crop protection, plant health and waterway systems
treatment that help customers operate more sustainably while
increasing their return on investment. MBI has screened over 18,000
microorganisms and 350 plant extracts, leveraging its in-depth
knowledge of plant and soil microbiomes enhanced by advanced
molecular technologies and natural product chemistry to rapidly
develop seven product lines. Supported by a robust portfolio of
over 400 issued and pending patents, MBI’s currently available
commercial products are Regalia®, Stargus®, Grandevo®, Venerate®,
Majestene®, Haven® and Amplitude®, Zelto® Jet-Oxide® and Jet-Ag®
and Zequanox®, with a breakthrough bioherbicide and biofumigant in
the Company’s product pipeline. MBI’s Finland-based subsidiary Pro
Farm® employs a proprietary technology derived from wood waste to
stimulate plant growth and improve plant health, resulting in
improved yields and crop quality. Products include Foramin®,
UBP-110™, LumiBio Valta™, LumiBio Kelta™.
Learn more about Marrone Bio Innovations
at www.marronebio.com. We also use our investor relations
website, https://investors.marronebio.com, as well as our corporate
Twitter account, @Marronebio, as means of disclosing material
non-public information, and encourage our investors and others to
monitor and review the information we make public in these
locations. Follow us on social
media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations
Contact: Pam Marrone, CEO and Founder Telephone: +1 (530)
750-2800Email: Info@marronebio.com
Investor Relations Contact:
Greg Falesnik Managing Director MZ Group – MZ North America Main:
949-385-6449MBII@mzgroup.uswww.mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Sep 2023 to Sep 2024